Understanding the role of endothelial cells in brain tumor formation and metastasis: a proposition to be explored for better therapy

Abolanle, 2020, Brain tumor: an overview of the basic clinical manifestations and treatment, Glob J Cancer Ther, 6, 038, 10.17352/2581-5407.000034 Ostrom, 2018, CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015, Neuro Oncol, 20, iv1, 10.1093/neuonc/noy131 Roth, 2021, Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO clinical practice guidelines for prophylaxis, diagnosis, treatment and follow-up, Ann Oncol, 32, 171, 10.1016/j.annonc.2020.11.003 Louis, 2021, The 2021 WHO classification of tumors of the central nervous system: a summary, Neuro Oncol, 23, 1231, 10.1093/neuonc/noab106 Louis, 2016, The 2016 World Health Organization classification of tumors of the central nervous system: a summary, Acta Neuropathol, 131, 803, 10.1007/s00401-016-1545-1 Tykocki, 2018, Ten-year survival in glioblastoma. A systematic review, J Clin Neurosci, 54, 7, 10.1016/j.jocn.2018.05.002 Verdugo, 2022, An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment, Cancer Commun, 42, 1083, 10.1002/cac2.12361 Ibrahim, 2021, Recent advances in the treatment of gliomas: the multimodal care therapy, Open Access Maced J Med Sci, 9, 503, 10.3889/oamjms.2021.6229 Liu, 2021, Advances in radiotherapy and comprehensive treatment of high-grade glioma: immunotherapy and tumor-treating fields, J Cancer, 12, 1094, 10.7150/jca.51107 Huang, 2017, Advances in immunotherapy for glioblastoma multiforme, J Immunol Res, 2017, 10.1155/2017/3597613 Mun, 2018, Tumor-treating fields: a fourth modality in cancer treatment, Clin Cancer Res, 24, 266, 10.1158/1078-0432.CCR-17-1117 Rana, 2021, Nanotherapeutics in tumour microenvironment for cancer therapy, Nanosci Nanotechnol-Asia, 11, 1 Qiao, 2021, Chemoattractants driven and microglia based biomimetic nanoparticle treating TMZ-resistant glioblastoma multiforme, J Control Release, 336, 54, 10.1016/j.jconrel.2021.06.015 Kumar, 2020, Nanoparticles for efficacious doxorubicin delivery both in vitro and in vivo, Nanoscale, 12, 1067, 10.1039/C9NR08475D Kadari, 2018, Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy, Eur J Pharm Biopharm, 132, 168, 10.1016/j.ejpb.2018.09.012 Kuo, 2016, Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy, Biotechnol Prog, 32, 480, 10.1002/btpr.2214 Li, 2017, Radioiodine-labeled anti-epidermal growth factor receptor binding bovine serum albumin-polycaprolactone for targeting imaging of glioblastoma, Oncol Rep, 38, 2919, 10.3892/or.2017.5937 Pandey, 2020, Hyaluronic acid-drug conjugate modified core-shell MOFs as pH responsive nanoplatform for multimodal therapy of glioblastoma, Int J Pharm, 588, 10.1016/j.ijpharm.2020.119735 Ying, 2018, Myristic acid-modified DA7R peptide for whole-process glioma-targeted drug delivery, ACS Appl Mater Interfaces, 10, 19473, 10.1021/acsami.8b05235 Song, 2017, Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG2000-transferrin in treatment of brain glioma, Eur J Pharm Sci, 96, 129, 10.1016/j.ejps.2016.09.024 Arcella, 2018, Brain targeting by liposome-biomolecular corona boosts anticancer efficacy of temozolomide in glioblastoma cells, ACS Chem Neurosci, 9, 3166, 10.1021/acschemneuro.8b00339 Gao, 2021, A virus-mimicking nucleic acid nanogel reprograms microglia and macrophages for glioblastoma therapy, Adv Mater, 33, 1, 10.1002/adma.202006116 Ziyad, 2011, Molecular mechanisms of tumor angiogenesis, Genes Cancer, 2, 1085, 10.1177/1947601911432334 Ahir, 2020, Tumor development and angiogenesis in adult brain tumor: glioblastoma, Mol Neurobiol, 57, 2461, 10.1007/s12035-020-01892-8 Lugano, 2020, Tumor angiogenesis: causes, consequences, challenges and opportunities, Cell Mol Life Sci, 77, 1745, 10.1007/s00018-019-03351-7 Krock, 2011, Hypoxia-induced angiogenesis: good and evil, Genes Cancer, 2, 1117, 10.1177/1947601911423654 Nishida, 2006, Angiogenesis in cancer, Vasc Health Risk Manag, 2, 213, 10.2147/vhrm.2006.2.3.213 Von Baumgarten, 2011, Bevacizumab has differential and dose-dependent effects on glioma blood vessels and tumor cells, Clin Cancer Res, 17, 6192, 10.1158/1078-0432.CCR-10-1868 Butowski, 2011, Anti-angiogenic therapy in glioma, Clin Transl Oncol, 13, 294, 10.1007/s12094-011-0657-2 Vennepureddy, 2017, Evolution of ramucirumab in the treatment of cancer – a review of literature, J Oncol Pharm Pract, 23, 525, 10.1177/1078155216655474 Quintero-Fabián, 2019, Role of matrix metalloproteinases in angiogenesis and cancer, Front Oncol, 9, 1, 10.3389/fonc.2019.01370 Presta, 2005, Fibroblast growth factor-2 in angiogenesis. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis, Cytokine Growth Factor Rev, 16, 159, 10.1016/j.cytogfr.2005.01.004 IF, 2000, Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs, J Neurooncol, 50, 121 Sarvaiya, 2013, Chemokines in tumor progression and metastasis, Oncotarget, 4, 2171, 10.18632/oncotarget.1426 Guo, 2003, Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment, Am J Pathol, 162, 1083, 10.1016/S0002-9440(10)63905-3 Cenciarelli, 2016, PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals, Oncotarget, 7, 53047, 10.18632/oncotarget.10132 Muppala, 2017, Thrombospondin-4 mediates TGF-β-induced angiogenesis, Oncogene, 36, 5189, 10.1038/onc.2017.140 Krishnan, 2015, Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition, Oncotarget, 6, 22480, 10.18632/oncotarget.4310 Brat, 2005, The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis, Neuro Oncol, 7, 122, 10.1215/S1152851704001061 Peshes-Yeloz, 2019, Role of klotho protein in tumor genesis, cancer progression, and prognosis in patients with high-grade glioma, World Neurosurg, 130, e324, 10.1016/j.wneu.2019.06.082 Melekhin, 2022, Investigation of the role of induced overexpression of the isolated secreted Klotho on the A-172 human glioblastoma cells, J Mol Neurosci, 72, 401, 10.1007/s12031-021-01960-1 Jiang, 2020, Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer, Mol Cancer, 19, 1, 10.1186/s12943-020-01178-6 Aloizou, 2020, The role of MiRNA-21 in gliomas: hope for a novel therapeutic intervention?, Toxicol Rep, 7, 1514, 10.1016/j.toxrep.2020.11.001 Folkman, 2008, Angiostatin and endostatin: angiogenesis inhibitors in blood and stroma, Angiogenes Integr Approach Sci Med, 129 Sun, 2001, Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice, Neoplasia, 3, 33, 10.1016/j.neo.2019.10.006 Paduch, 2016, The role of lymphangiogenesis and angiogenesis in tumor metastasis, Cell Oncol, 39, 397, 10.1007/s13402-016-0281-9 Liu, 2017, Basic fibroblast growth factor as a potential biomarker for diagnosing malignant tumor metastasis in women, Oncol Lett, 14, 1561, 10.3892/ol.2017.6335 Zetter, 1998, Angiogenesis and tumor metastasis, Annu Rev Med, 49, 407, 10.1146/annurev.med.49.1.407 Lu, 2015, Circulating tumor cell clusters-associated gene plakoglobin and breast cancer survival, Breast Cancer Res Treat, 151, 491, 10.1007/s10549-015-3416-1 Aceto, 2014, Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis, Cell, 158, 1110, 10.1016/j.cell.2014.07.013 Folkman, 1990, What is the evidence that tumors are angiogenesis dependent?, J Natl Cancer Inst, 82, 4, 10.1093/jnci/82.1.4 Ogawa, 1995, Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen, Br J Cancer, 71, 1297, 10.1038/bjc.1995.251 Guex, 2015, Angiogenic activity of breast cancer patients’ monocytes reverted by combined use of systems modeling and experimental approaches, PLoS Comput Biol, 11, 1, 10.1371/journal.pcbi.1004050 Rak, 1995, Consequences of angiogenesis for tumor progression, metastasis and cancer therapy, Anticancer Drugs, 6, 3, 10.1097/00001813-199502000-00001 van, 2011, Initial steps of metastasis: cell invasion and endothelial transmigration, Mutat Res, 728, 23 Sanz-Moreno, 2008, Rac activation and inactivation control plasticity of tumor cell movement, Cell, 135, 510, 10.1016/j.cell.2008.09.043 Paul, 2017, Cancer cell motility: lessons from migration in confined spaces, Nat Rev Cancer, 17, 131, 10.1038/nrc.2016.123 Mierke, 2008, Role of the endothelium during tumor cell metastasis: is the endothelium a barrier or a promoter for cell invasion and metastasis?, J Biophys, 1, 10.1155/2008/183516 Chiang, 2016, Tumor cell intravasation, Am J Physiol - Cell Physiol, 311, C1, 10.1152/ajpcell.00238.2015 Reymond, 2013, Crossing the endothelial barrier during metastasis, Nat Rev Cancer, 13, 858, 10.1038/nrc3628 Valastyan, 2011, Tumor metastasis: molecular insights and evolving paradigms, Cell, 147, 275, 10.1016/j.cell.2011.09.024 Weis, 2011, αV integrins in angiogenesis and cancer, Cold Spring Harb Perspect Med, 1, 10.1101/cshperspect.a006478 Wrobel, 2016, Blood–brain barrier remodeling during brain metastasis formation, Mol Med, 22, 32, 10.2119/molmed.2015.00207 Lugano, 2020, Tumor angiogenesis: causes, consequences, challenges and opportunities, Cell Mol Life Sci, 77, 1745, 10.1007/s00018-019-03351-7 Duffy A.M., Bouchier-Hayes D.J., Harmey J.H. Vascular endothelial growth factor (VEGF) and its role in non-endothelial cells: autocrine signalling by VEGF. In: Madame Curie Bioscience Database [Internet]. Austin (TX): Landes Bioscience; 2013; 2000-2013. Available from: https://www.ncbi.nlm.nih.gov/books/NBK6482/. Rajendran, 2013, The vascular endothelium and human diseases, Int J Biol Sci, 9, 1057, 10.7150/ijbs.7502 Chen, 2018, Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial–mesenchymal transition, Onco Targets Ther, 11, 3817, 10.2147/OTT.S168317 Herman, 2019, Paracellular and transcellular migration of metastatic cells through the cerebral endothelium, J Cell Mol Med, 23, 2619, 10.1111/jcmm.14156 Gligorijevic, 2012, N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors, J Cell Sci, 125, 724, 10.1242/jcs.092726 Li, 2014, The Notch Ligand Jagged1 as a target for anti-tumor therapy, Front Oncol, 4, 254, 10.3389/fonc.2014.00254 Miles, 2008, Stepping out of the flow: capillary extravasation in cancer metastasis, Clin Exp Metastasis, 25, 305, 10.1007/s10585-007-9098-2 Wilhelm, 2013, Role of the blood-brain barrier in the formation of brain metastases, Int J Mol Sci, 14, 1383, 10.3390/ijms14011383 Ito, 2001, Real-time observation of micrometastasis formation in the living mouse liver using a green fluorescent protein gene-tagged rat tongue carcinoma cell line, Int J Cancer, 93, 212, 10.1002/ijc.1318 Wrobel, 2016, Blood–brain barrier remodeling during brain metastasis formation, Mol Med, 22, 32, 10.2119/molmed.2015.00207 Khuon, 2010, Myosin light chain kinase mediates transcellular intravasation of breast cancer cells through the underlying endothelial cells: a three-dimensional FRET study, J Cell Sci, 123, 431, 10.1242/jcs.053793 Reymond, 2013, Crossing the endothelial barrier during metastasis, Nat Rev Cancer, 13, 858, 10.1038/nrc3628 Schuldes, 1997, Loss of in vitro cytotoxicity of cisplatin after storage as stock solution in cell culture medium at various temperatures, Cancer, 79, 1723, 10.1002/(SICI)1097-0142(19970501)79:9<1723::AID-CNCR13>3.0.CO;2-# Huh, 2010, Tumor and stem cell biology transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development, Cancer Res, 70, 6071, 10.1158/0008-5472.CAN-09-4442 Yoshimasu, 2004, Increased expression of integrin α3β1 in highly brain metastatic subclone of a human non-small cell lung cancer cell line, Cancer Sci, 95, 142, 10.1111/j.1349-7006.2004.tb03195.x Orian-Rousseau, 2010, CD44, a therapeutic target for metastasising tumours, Eur J Cancer, 46, 1271, 10.1016/j.ejca.2010.02.024 Desgrosellier, 2010, Integrins in cancer: biological implications and therapeutic opportunities, Nat Rev Cancer, 10, 9, 10.1038/nrc2748 Amato, 2020, Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer, Int J Mol Sci, 21, 7777, 10.3390/ijms21207777 Garofalo, 2017, Environmental stimuli shape microglial plasticity in glioma, Elife, 6, e33415, 10.7554/eLife.33415 Garofalo, 2015, Enriched environment reduces glioma growth through immune and non-immune mechanisms in mice, Nat Commun, 6, 6623, 10.1038/ncomms7623 Jalkanen, 2007, The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding, Blood, 110, 1864, 10.1182/blood-2007-01-069674 Kappelmayer, 2017, The interaction of selectins and PSGL-1 as a key component in thrombus formation and cancer progression, Biomed Res Int, 10.1155/2017/6138145 McEver, 2010, Rolling cell adhesion, Annu Rev Cell Dev Biol, 26, 363, 10.1146/annurev.cellbio.042308.113238 Takeichi, 1992, Cytoplasmic control of cadherin-mediated cell-cell adhesion, Cold Spring Harb Symp Quant Biol, 57, 327, 10.1101/SQB.1992.057.01.037 J, 1990, The transforming growth factor-beta family, Annu Rev Cell Biol, 6, 597, 10.1146/annurev.cb.06.110190.003121 Wesolowska, 2008, Microglia-derived TGF-β as an important regulator of glioblastoma invasion - an inhibition of TGF-β-dependent effects by shRNA against human TGF-β type II receptor, Oncogene, 27, 918, 10.1038/sj.onc.1210683 Lange, 1999, Expression of TGF-β related Smad proteins in human epithelial skin tumors, Int J Oncol, 14, 1049 Bruna, 2007, High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene, Cancer Cell, 11, 147, 10.1016/j.ccr.2006.11.023 Miraux, 2004, Inhibition of FGF receptor activity in glioma implanted into the mouse brain using the tetracyclin-regulated expression system, Angiogenesis, 7, 105, 10.1007/s10456-004-1037-0 Mignatti, 1991, Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor, J Cell Biol, 113, 1193, 10.1083/jcb.113.5.1193 Montesano, 1986, Basic fibroblast growth factor induces angiogenesis in vitro, Proc Natl Acad Sci USA, 83, 7297, 10.1073/pnas.83.19.7297 Plate, 1992, Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo, Nature, 359, 845, 10.1038/359845a0 de Vries, 1992, The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor, Science, 255, 989, 10.1126/science.1312256 Terman, 1992, Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor, Biochem Biophys Res Commun, 187, 1579, 10.1016/0006-291X(92)90483-2 Tate, 2009, Biology of angiogenesis and invasion in glioma, Neurotherapeutics, 6, 447, 10.1016/j.nurt.2009.04.001 Lee, 2004, Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice, Clin Exp Metastasis, 21, 107, 10.1023/B:CLIN.0000024761.00373.55 Criscuoli, 2005, Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability, Blood, 105, 1508, 10.1182/blood-2004-06-2246 Shih, 2006, Platelet-derived growth factor (PDGF) and glial tumorigenesis, Cancer Lett, 232, 139, 10.1016/j.canlet.2005.02.002 Guo, 2003, Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment, Am J Pathol, 162, 1083, 10.1016/S0002-9440(10)63905-3 Reis, 2012, Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression, J Exp Med, 209, 1611, 10.1084/jem.20111580 Zhang, 2015, Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas, Sci Signal, 8, ra125, 10.1126/scisignal.aaa1690 González-Castillo, 2015, Pleiotrophin as a central nervous system neuromodulator, evidences from the hippocampus, Front Cell Neurosci, 8, 443, 10.3389/fncel.2014.00443 Banerjee, 2021, Current approaches for glioma gene therapy and virotherapy, Front Mol Neurosci, 14, 621831, 10.3389/fnmol.2021.621831 Dong, 2009, Transcriptional targeting of tumor endothelial cells for gene therapy, Adv Drug Deliv Rev, 61, 542, 10.1016/j.addr.2009.02.006 Demeule, 2004, Brain endothelial cells as pharmacological targets in brain tumors, Mol Neurobiol, 30, 157, 10.1385/MN:30:2:157 Charalambous, 2006, Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme, Neurosurg Focus, 20, E22, 10.3171/foc.2006.20.4.e22 Moore, 2004, Endothelial progenitor cells' "homing" specificity to brain tumors, Gene Ther, 11, 811, 10.1038/sj.gt.3302151 Zarebkohan, 2016, SRL-coated PAMAM dendrimer nano-carrier for targeted gene delivery to the glioma cells and competitive inhibition by lactoferrin, Iran J Pharm Res, 15, 629 Green, 2006, Biodegradable polymeric vectors for gene delivery to human endothelial cells, Bioconjug Chem, 17, 1162, 10.1021/bc0600968 Suh, 2002, An angiogenic, endothelial-cell-targeted polymeric gene carrier, Mol Ther, 6, 664, 10.1016/S1525-0016(02)90721-5 Marchiò, 2016, Brain endothelial cell-targeted gene therapy of neurovascular disorders, EMBO Mol Med, 8, 592, 10.15252/emmm.201606407 Merkel, 2017, Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells, J Neurochem, 140, 216, 10.1111/jnc.13861 Khalilov, 2023, A comprehensive review of advanced nano-biomaterials in regenerative medicine and drug delivery, Adv Biol Earth Sci, 8, 5 Eftekhari, 2023, Natural and synthetic nanovectors for cancer therapy, Nanotheranostics, 7, 236, 10.7150/ntno.77564 Carlson, 2021, Identification of diverse tumor endothelial cell populations in malignant glioma, Neuro Oncol, 23, 932, 10.1093/neuonc/noaa297 Li, 2019, Glioma-associated human endothelial cell-derived extracellular vesicles specifically promote the tumourigenicity of glioma stem cells via CD9, Oncogene, 38, 6898, 10.1038/s41388-019-0903-6 Nguyen Cao, 2023, Brain endothelial cell-derived extracellular vesicles with a mitochondria-targeting photosensitizer effectively treat glioblastoma by hijacking the blood‒brain barrier, Acta Pharm Sin B, 10.1016/j.apsb.2023.03.023 Kudo, 2007, Inhibition of tumor growth through suppression of angiogenesis by brain-specific angiogenesis inhibitor 1 gene transfer in murine renal cell carcinoma, Oncol Rep, 18, 785 Chen, 2022, Efficacy, safety, and challenges of CAR T-cells in the treatment of solid tumors, Cancers, 14, 1, 10.3390/cancers14235983 Transl, 2020, Chimeric antigen receptor T-cell therapy in glioblastoma : charging the T cells to fight, J Transl Med, 18, 428, 10.1186/s12967-020-02598-0 Li, 2021, Improving antitumor immunity using antiangiogenic agents: mechanistic insights, current progress, and clinical challenges, Cancer Commun, 41, 830, 10.1002/cac2.12183 Nagl, 2020, Tumor endothelial cells (TECs) as potential immune directors of the tumor microenvironment-new findings and future perspectives, Front Cell Dev Biol, 8, 1, 10.3389/fcell.2020.00766 Habashy, 2022, Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them, Br J Cancer, 127, 976, 10.1038/s41416-022-01864-w Polivka, 2017, Advances in experimental targeted therapy and immunotherapy for patients with glioblastoma multiforme, Anticancer Res, 37, 21, 10.21873/anticanres.11285 Ratnam, 2019, Immunotherapy in CNS cancers: the role of immune cell trafficking, Neuro Oncol, 21, 37, 10.1093/neuonc/noy084 Zhang, 2022, Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy, Adv Drug Deliv Rev, 186, 10.1016/j.addr.2022.114319 Lamplugh, 2021, Vascular microenvironment, tumor immunity and immunotherapy, Front Immunol, 12, 1, 10.3389/fimmu.2021.811485 Ma, 2021, Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma, Nat Cancer, 2, 83, 10.1038/s43018-020-00147-8 Yang, 2021, Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40, Nat Commun, 12, 1 Hua, 2022, Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop, Cancer Cell, 40, 10.1016/j.ccell.2022.11.002 Duru, 2020, A window of opportunity: targeting cancer endothelium to enhance immunotherapy, Front Immunol, 11, 1, 10.3389/fimmu.2020.584723